Future perspectives of Sleeping Beauty transposon system in cancer research
Xiu Chen, Di Xu, Jian Zhang, Jinhai Tang
Abstract
Open-access reader
Xiu Chen, Di Xu, Jian Zhang, Jinhai Tang
Abstract
Open-access reader
With the unsolved challenges to explore potential predictors of metastasis in colorectal cancer patients, Nicoloso and colleagues endeavored in this issue to combine a transposon-based forward genetic screen with the forced Single Cell Suspension assay (fSCS) to discover specific regulators of metastatic colorectal cancer [1]. They found that the fSCS was a simple and scalable in vitro assay to select cells with pro-metastatic traits. Meanwhile, the Sleeping Beauty transposon integration was proven to generate fSCS-resistant colorectal cancer cells.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
With the unsolved challenges to explore potential predictors of metastasis in colorectal cancer patients, Nicoloso and colleagues endeavored in this issue to combine a transposon-based forward genetic screen with the forced Single Cell Suspension assay (fSCS) to discover specific regulators of metastatic colorectal cancer [1]. They found that the fSCS was a simple and scalable in vitro assay to select cells with pro-metastatic traits. Meanwhile, the Sleeping Beauty transposon integration was proven to generate fSCS-resistant colorectal cancer cells.
Key concepts: Colorectal cancer, Metastasis, Medicine, Cancer, Sleeping Beauty transposon system, Oncology, Internal medicine, Bioinformatics